A rigorous approach for selection of optimal variant sets for carrier screening with demonstration of clinical utility

Publisher： John Wiley & Sons Inc

E-ISSN： 2324-9269|3|4|363-373

ISSN： 2324-9269

Source： Molecular Genetics & Genomic Medicine, Vol.3, Iss.4, 2015-07, pp. : 363-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Debating Clinical Utility

By  

Public Health Genomics, Vol. 13, Iss. 4, 2010-04 ,pp. : 215-223

Karger

Access to resources Recommend Favorite

Is Cystic Fibrosis Carrier Screening Cost Effective?

By  

Public Health Genomics, Vol. 10, Iss. 2, 2007-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Hereditary Nonpolyposis Colorectal Cancer: An Approach to the Selection of Candidates to Genetic TestingBased on Clinical and MolecularCharacteristics

By  

Public Health Genomics, Vol. 1, Iss. 4, 1999-06 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Carrier screening by next‐generation sequencing: health benefits and cost effectiveness

By  

Molecular Genetics & Genomic Medicine, Vol. 4, Iss. 3, 2016-05 ,pp. : 292-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions

By Yu Wei   Ballif Blake C.   Kashork Catherine D.   Heilstedt Heidi A.   Howard Leslie A.   Cai Wei-Wen   White Lisa D.   Liu Wenbin   Beaudet Arthur L.   Bejjani Bassem A.   Shaw Chad A.  

Human Molecular Genetics, Vol. 12, Iss. 17, 2003-09 ,pp. : 2145-2152

Oxford University Press

Access to resources Recommend Favorite